WHO ICTRP trial
Molecular diagnostic value of MANF on lung injury in sepsis and its role in…
ChiCTR2200060529 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200060529 |
|---|---|
| Public title | Molecular diagnostic value of MANF on lung injury in sepsis and its role in regulating endoplasmic reticulum stress affecting the outcome of lung injury in sepsis and its mechanism |
| Scientific title | Molecular diagnostic value of MANF on lung injury in sepsis and its role in regulating endoplasmic reticulum stress affecting the outcome of lung injury in sepsis and its mechanism |
| Primary sponsor | West China Hospital of Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Basic Science |
| Countries | China |
| Conditions | Sepsis |
| Interventions | Sepsis group:None;Control group:None |
| Registration date | Jun 4, 2022 |
| Target size | Sepsis group:20;Control group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: